RJH Biosciences announce a grant from the Bill & Melinda Gates Foundation to develop a new device to enable 'Immunotherapy On-the-Go'.
Edmonton-based Metabolomic Technologies Inc., who are developing metabolomics-based in vitro diagnostics, announced the successful completion of a $4.2 million dollar Series A raise.
Nanostics announce the expansion of the APCaRI co-sponsored ClarityDX Prostate clinical validation study into the US, with the opening of a recruitment site at Century Clinical Research Inc. in Daytona Beach, Florida.
BioAlberta congratulates Metabolomic Technologies Inc. and Dr. Matt Coffey, and celebrates Drs. Jacqueline Shan and Richard Fedorak as they are inducted into Bioindustry Hall of Fame in 2019
Innovation continues to revolutionize many sectors in Canada's economy. Through a wide range of programs available to businesses and institutions, researchers, and entrepreneurs, the GoC is ensuring businesses in Northern Alberta remain competitive ...
HRF of Innovative Medicines Canada will award two research Fellowships in the area of Artificial Intelligence (AI) Health Research in its impact on health care in Canada.
NPC conducted a survey with key stakeholders within the ecosystem in 2018, and the results have led to the development of three programs designed to address key gaps in the commercialization process
SmileSonica Inc.'s Aevo System™ facilitates faster tooth movement and decreases orthodontically induced tooth root resorption during orthodontic treatment.
A tri-party collaboration will focus on developing solutions to address treatment gaps in the area of COPD care and its associated co-morbidities.
Parvus Eligible to Receive Upfront and Milestone Payments Exceeding $800 Million Plus Royalties on Net Sales
Alberta Government and Pfizer Canada provide an additional $1.3 million contribution to the
Pfizer-Alberta Collaboration in Health.
MindBytes BVBA and its subsidiary, MindLab Interactive AI Inc., announce its first peer-reviewed manuscript was published in the open access journal JMIR Serious Games.
For the 4th consecutive year, Bioneutra Global Corp. joins the business giants of Canada on Globe And Mail's 2019 list of 'Top 1000'
Developed by Metabolomic Technologies Inc., PolypDx - the first and only urine-based test for the detection and prevention of colorectal cancer.